Top-News

BioDelivery Sciences International News

Aktie
WKN:  766464 ISIN:  US09060J1060 US-Symbol:  BDSI
Keine aktuellen Kursdaten verfügbar
Handeln Depot/Watchlist
Dieses Wertpapier ist nicht mehr handelbar.
Aktienanzahl *
98,60 Mio.
Marktkapitalisierung *
-
Streubesitz
-
Index-Zugehörigkeit
Nasdaq Composite Index
IR-Website
zur Website
*Stand: 17.08.2021

BioDelivery Sciences International News

01.03.22 - PR Newswire
SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates SJI, OBNK, CTXS, BDSI
SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates SJI, OBNK, CTXS, BDSI PR Newswire
28.02.22 - PR Newswire
SHAREHOLDER ALERT: WeissLaw LLP Reminds BDSI, MIME, VRS, and EPAY Shareholders About Its Ongoing Investigations
SHAREHOLDER ALERT: WeissLaw LLP Reminds BDSI, MIME, VRS, and EPAY Shareholders About Its Ongoing Investigations PR Newswire
21.02.22 - PR Newswire
SHAREHOLDER ALERT: WeissLaw LLP Reminds BDSI, FTSI, CCMP, and FLOW Shareholders About Its Ongoing Investigations
SHAREHOLDER ALERT: WeissLaw LLP Reminds BDSI, FTSI, CCMP, and FLOW Shareholders About Its Ongoing Investigations PR Newswire
16.02.22 - PR Newswire
BIODELIVERY SCIENCES INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of BioDelivery Sciences International, Inc. - BDSI
BIODELIVERY SCIENCES INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in ...
14.02.22 - PR Newswire
Shareholder Alert: The M&A Class Action Firm is Investigating the Merger of BDSI, ZWS, RRD, QDEL, RC, TACO
Shareholder Alert: The M&A Class Action Firm is Investigating the Merger of BDSI, ZWS, RRD, QDEL, RC, TACO PR Newswire
14.02.22 - PR Newswire
Shareholder Alert: Ademi LLP investigates whether BioDelivery Sciences International, Inc. has obtained a Fair Price in its transaction with Collegium.
Shareholder Alert: Ademi LLP investigates whether BioDelivery Sciences International, Inc. has obtained a Fair Price in its transaction with Collegium. PR Newswire
14.02.22 - PR Newswire
Thinking about buying stock in BioDelivery Sciences, China Online Education, Gold Fields, Y-mAbs Therapeutics, or Bloom Energy?
Thinking about buying stock in BioDelivery Sciences, China Online Education, Gold Fields, Y-mAbs Therapeutics, or Bloom Energy? PR Newswire
03.02.21 - PR Newswire
An Aging Population is Increasing the Need for Novel Treatments
An Aging Population is Increasing the Need for Novel Treatments FN Media Group Presents Microsmallcap.com Market Commentary PR Newswire
11.12.19 - PR Newswire
Emmy® and Tony Award® Winning Actress Kristin Chenoweth Introduces 'This Is Pain' Campaign to Improve the Lives of Those Living with Chronic Pain
Emmy® and Tony Award® Winning Actress Kristin Chenoweth Introduces 'This Is Pain' Campaign to Improve the Lives of Those Living with Chronic Pain Chenoweth Partners with ...
29.07.19 - PR Newswire
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating BioDelivery Sciences International, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating BioDelivery Sciences International, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR ...
22.03.19 - PR Newswire
Lifshitz & Miller LLP Announces Investigation of Alta Mesa Resources, Inc., American Renal Associates LLC, Belden, Inc., BioDelivery Sciences, Inc., Blue Valley Bank Corp., Bridgepoint Education, Inc., and Care.com, Inc.
Lifshitz & Miller LLP Announces Investigation of Alta Mesa Resources, Inc., American Renal Associates LLC, Belden, Inc., BioDelivery Sciences, Inc., Blue Valley Bank Corp., ...
14.03.19 - ACCESSWIRE
BioDelivery Sciences Reports Strong 2018 Results and 2019 Expectations
BELBUCA® prescription growth further accelerated to an all-time high during the fourth quarter Company increases Belbuca 2019 net sales expectations to $80-$85 million ...
27.11.17 - PR Newswire
BioDelivery Sciences Announces Ohio Workers Compensation Adding BELBUCA and BUNAVAIL to Formulary
BioDelivery Sciences Announces Ohio Workers Compensation Adding BELBUCA and BUNAVAIL to Formulary Action taken as part of response to opioid crisis in State PR Newswire
16.11.17 - PR Newswire
BioDelivery Sciences to Present at the 29th Annual Piper Jaffray Conference
BioDelivery Sciences to Present at the 29th Annual Piper Jaffray Conference Presentation to highlight ongoing BELBUCA success PR Newswire
03.11.17 - PR Newswire
Stull, Stull & Brody Announces Investigation Relating to Potential Securities Law Violations by BioDelivery Sciences International, Inc. (NASDAQ:BDSI)
Stull, Stull & Brody Announces Investigation Relating to Potential Securities Law Violations by BioDelivery Sciences International, Inc. (NASDAQ:BDSI) PR Newswire
30.10.17 - PR Newswire
BioDelivery Sciences to Host Conference Call and Webcast Reporting Third Quarter 2017 Financial Results on November 9
BioDelivery Sciences to Host Conference Call and Webcast Reporting Third Quarter 2017 Financial Results on November 9 PR Newswire
12.10.17 - PR Newswire
BioDelivery Sciences Announces Patent Litigation Settlement Agreement with Teva
BioDelivery Sciences Announces Patent Litigation Settlement Agreement with Teva PR Newswire
06.10.17 - PR Newswire
BioDelivery Sciences Participates in U.S. Department of Health and Human Services Round Table Discussion on Pain Management and Opioid Dependence
BioDelivery Sciences Participates in U.S. Department of Health and Human Services Round Table Discussion on Pain Management and Opioid Dependence PR Newswire
19.09.17 - PR Newswire
BioDelivery Sciences to Present at the Cantor Fitzgerald Global Healthcare Conference and the Ladenburg Thalmann 2017 Healthcare Conference
BioDelivery Sciences to Present at the Cantor Fitzgerald Global Healthcare Conference and the Ladenburg Thalmann 2017 Healthcare Conference PR Newswire
12.09.17 - PR Newswire
BioDelivery Sciences Announces Granting of Market Authorization Transfer by Health Canada for BELBUCA® and Associated Milestone Payment
BioDelivery Sciences Announces Granting of Market Authorization Transfer by Health Canada for BELBUCA® and Associated Milestone Payment Transfer of NDS to Purdue Pharma ...

Newssuche

Videos

newspaper
07.05.24 +5,69%
Technical Trading: DAX Long kurzfristig
DAX Long Typ: Turbo Open End WKN: NG8K9X Hebel: 26 Laufzeit: OpenEnd Einstieg: Market ... Mehr »